To investigate the incidence, clinical characteristics and prognosis of acute ischemic and hemorrhagic cerebrovascular disease secondary to the implantation of cardiovascular implantable electronic devices, so as to provide a basis for subsequent treatment strategies and risk factor stratification. This study intends to retrospectively collect the incidence and case characteristics of acute cerebral infarction, cerebral embolism, transient ischemic attack and cerebral hemorrhage in CIED patients admitted to the First Affiliated Hospital of Xi 'an Jiaotong University and other centers from January 2012 to September 2022. Then, the incidence of poor prognosis and related factors of patients within 3 months were followed up by telephone to provide a basis for subsequent treatment strategy and risk factor stratification.
Study Type
OBSERVATIONAL
Enrollment
13,324
Cardiac electronic implants(CIED) includes permanent pacemaker (PPM), implantable cardioverter defibrillator (ICD), three-chamber pacemaker for cardiac resynchronization therapy defibrillator, lead free pacemaker, etc.
Guoliang Li
Xi'an, Shannxi Province, China
The incidence of acute cerebrovascular disease
Number and rate of patients with acute cerebrovascular disease secondary to patients receiving cardiac electronic implants. The data were obtained from the medical records.
Time frame: About 4 weeks after the enrollment
In-hospital mortality
In-hospital mortality of acute cerebrovascular disease in patients receiving cardiac electronic implants. The data were obtained from the medical records.
Time frame: About 4 weeks after the enrollment
All-cause mortality
All-cause mortality within 3 months of telephone follow-up.
Time frame: 3 months after the enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.